Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans

This study looks at whether simple, non-invasive blood test scores can predict the risk of developing liver cancer in people with advanced liver disease who have been cured of hepatitis C. Researchers analyzed data from 571 adults treated at a single hospital over ten years. The goal is to find a group of patients with such low risk that they might safely skip routine liver cancer surveillance.